PostEra is building a modern 21st century biopharma. We use Proton, our AI platform for medicinal chemistry, to accelerate the discovery of new cures for patients. PostEra is advancing an internal pipeline in Women's Health and Fertility, while advancing small molecule programs through partnerships with pharma. We've closed over $1Bn in AI partnerships including 4 multi-year agreements with Pfizer and Amgen. PostEra is also leading an antiviral drug discovery center for pandemic preparedness, funded by one of the largest grants in NIH history.
| Website | http://www.postera.ai |
| Revenue | $9.3 million |
| Employees | 43 (39 on RocketReach) |
| Founded | 2019 |
| Industry | Biotechnology Research, Other Healthcare Technology Systems, Business/Productivity Software |
| Keywords | Drug Discovery, Machine Learning, Artificial Intelligence, Medicinal Chemistry, Ai Platform, Biopharma, Pharmaceutical, Drug Development, Biotechnology, Deep Learning, Computational Chemistry, Technology, Healthcare, Therapeutics, Precision Medicine, Life Sciences, Data Science, Innovation, Research |
| Competitors | Schrödinger, Synthego Corporation, Insilico Medicine, OpenEye, Cadence Molecular Sciences, XtalPi Inc., Chemaxon, Atomwise, BenevolentAI, Cresset software and discovery, PureLynx +37 more (view full list) |
Looking for a particular PostEra employee's phone or email?
The PostEra annual revenue was $9.3 million in 2026.
Aaron Morris is the CEO and Co-Founder of PostEra.
39 people are employed at PostEra.